Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature

Posttransplant Tacrolimus-Induced Diabetic Ketoacidosis: Review of the Literature

Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after k...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Case reports in endocrinology 2018-01, Vol.2018 (2018), p.1-6
Hauptverfasser: Alfonso-Jaume, Maria A., Tiwari, Abhinav, Dasa, Osama, Ruzieh, Mohammed, Pak, Stella C., Ammari, Zaid, Jaume, Juan C.
Format: Artikel
Sprache:eng
Schlagworte:
Abdomen
Anorexia
Bone marrow
Case Report
Case reports
Complications and side effects
Diabetes
Diabetic acidosis
Diabetic ketoacidosis
Drug dosages
Emergency medical care
Gene expression
Glucose
Hyperglycemia
Insulin
Ketoacidosis
Kidney diseases
Kidneys
Liver
Mycophenolate sodium
Pain
Patients
Risk factors
Tacrolimus
Transplantation
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
ISSN:2090-6501
2090-651X
DOI:10.1155/2018/4606491